
Section | Page |
Letter to Shareholders and Management’s Discussion of Fund Performance | |
Summary of Certain Unaudited Portfolio Characteristics | |
Fees and Expenses | |
Statement of Assets and Liabilities | |
Schedule of Investments | |
Statement of Operations | |
Statements of Changes in Net Assets | |
Statement of Cash Flows | |
Financial Highlights | |
Notes to Financial Statements | |
Dividend Reinvestment Plan | |
Portfolio Proxy Voting Policies and Proxy Voting Record | |
Additional Information |



Summary of Underlying Portfolio | |
Number of Unique Underlying Loan Obligors | 1,423 |
Number of Underlying Loans | 1,850 |
Aggregate Balance of Underlying Loans | $17.89 Billion |
Average Individual Loan Obligor Exposure | 0.07% |
Currency: USD Exposure | 100.00% |
Aggregate Indirect Exposure to Senior Secured Loans | 97.18% |
Weighted Average Junior OC Cushion | 4.18% |
Weighted Average Market Price of Loan Collateral | 94.32 |
Weighted Average Remaining CLO Reinvestment Period | 3.28 years |
CCIF’s Last 12 Month Default Rate including Distressed Exchanges of Underlying Loans | 1.18% |
Loan Market Default Rate including Distressed Exchanges | 3.04% |
Top 10 Underlying Obligors | |
Obligor | % Total |
TransDigm | 0.60% |
Hologic | 0.46% |
TIBCO Software | 0.44% |
Citadel Securities LP | 0.44% |
Jane Street Group | 0.44% |
Acrisure | 0.42% |
Quikrete Companies | 0.41% |
Sedgwick Claims Management Service | 0.40% |
Ensemble RCM | 0.40% |
Belron FIN 2019 | 0.40% |
Total | 4.41% |
Top 10 Industries of Underlying Obligors | |
Industry | % Total |
Healthcare & Pharmaceuticals | 12.13% |
High Tech | 12.07% |
Banking, Finance, Insurance & Real Estate | 10.25% |
Services: Business | 8.62% |
Hotels, Gaming & Leisure | 5.15% |
Capital Equipment | 4.81% |
Beverage, Food & Tobacco | 4.37% |
Construction & Building | 4.08% |
Aerospace & Defense | 3.81% |
Energy: Oil & Gas | 3.66% |
Total | 68.95% |




SHAREHOLDER TRANSACTION FEES | ||
Sales load | (1) | |
Offering expenses borne by the Fund | (2) | |
Dividend reinvestment plan expenses | (3) | |
Total shareholder transaction fees | —% | (4) |
ESTIMATED ANNUAL FUND EXPENSES (as a percentage of net assets attributable to common shares) | ||
Management Fee | (5) | |
Incentive Fee payable under Investment Advisory Agreement (17.5%) | (6) | |
Interest payments and fees on borrowed funds | (7) | |
Other Expenses | (8) | |
Total annual fund expenses |
Example | 1 Year | 3 Years | 5 Years | 10 Years |
Expenses on a $1,000 investment, assuming a 5% annual return | $ | $ | $ | $ |
March 31, 2026 | ||
ASSETS | ||
Investments, at fair value (cost $174,665,811) | $122,889,556 | |
Cash and cash equivalents | 2,812,913 | |
Interest receivable | 3,610,272 | |
Deferred financing costs | 560,107 | |
Prepaid expenses | 163,490 | |
Total assets | $130,036,338 | |
LIABILITIES | ||
Preferred Shares (net of unamortized deferred issuance costs of $1,744,233) (Note 7) | $49,272,767 | |
Secured credit facility | 8,000,000 | |
Incentive fee payable | 253,737 | |
Management fee payable | 393,621 | |
Professional fees payable | 309,736 | |
Interest payable | 261,081 | |
Administration and custodian fees payable | 256,427 | |
Other payables and accrued expenses | 439,495 | |
Total liabilities | $59,186,864 | |
COMMITMENTS AND CONTINGENCIES (Note 8) | ||
Net Assets | $70,849,474 | |
COMPOSITION OF NET ASSETS | ||
Paid-in capital | $151,629,695 | |
Total distributable earnings (losses) | (80,780,221) | |
Total Net Assets | $70,849,474 | |
Common shares outstanding (no par value) | 21,198,622 | |
Net asset value per share of common stock | $3.34 |
Issuer (1)(7) | Investment Description | Acquisition Date (2) | Principal Amount | Cost | Fair Value (3) | % of Net Assets |
CLO - Equity(4)(5) | ||||||
522 Funding CLO 2021-7, Ltd. | Subordinated Notes (effective yield 0.00%, 4/23/2034)8 | 7/27/2023 | $4,505,000 | $266,073 | $27,030 | 0.04% |
AGL CLO 17, Ltd. | Subordinated Notes (effective yield 9.76%, 1/21/2035) | 5/6/2024 | 2,750,000 | 1,802,209 | 805,166 | 1.15% |
Aimco CLO 10, Ltd. | Subordinated Notes (effective yield 8.27%, 7/22/2032) | 11/27/2023 | 11,071,800 | 5,860,213 | 4,484,055 | 6.33% |
Aimco CLO 14, Ltd. | Subordinated Notes (effective yield 10.23%, 10/20/2038) | 7/17/2023 | 6,200,000 | 4,543,138 | 3,581,394 | 5.05% |
Allegro XVII, Ltd. | Subordinated Notes (effective yield 13.70%, 7/25/2038) | 5/07/2025 | 1,875,000 | 1,488,932 | 1,134,987 | 1.60% |
Apidos CLO XXV, Ltd. | Subordinated Notes (effective yield 0.00%, 1/20/2037)8 | 7/1/2025 | 6,000,000 | 1,769,368 | 1,496,784 | 2.11% |
Apidos CLO XXXIII, Ltd. | Subordinated Notes (effective yield 9.87%, 10/24/2034)6 | 7/25/2024 | 22,780,000 | 12,053,371 | 9,770,868 | 13.79% |
Apidos CLO XXXIX, Ltd. | Subordinated Notes (effective yield 11.18%, 10/21/2038) | 5/2/2024 | 7,058,000 | 4,477,670 | 3,548,254 | 5.01% |
Ares LIX CLO, Ltd. | Subordinated Notes (effective yield 18.85%, 4/25/2034) | 12/7/2023 | 8,000,000 | 4,125,084 | 2,231,943 | 3.15% |
Ares LV CLO, Ltd. | Subordinated Notes (effective yield 11.40%, 10/15/2037) | 8/19/2025 | 7,500,000 | 5,055,380 | 3,330,010 | 4.70% |
Ares LVI CLO, Ltd. | Subordinated Notes (effective yield 14.14%, 1/25/2038) | 8/24/2023 | 4,751,000 | 2,726,273 | 2,076,736 | 2.93% |
Ares LX CLO, Ltd. | Subordinated Notes (effective yield 21.35%, 7/18/2034) | 11/29/2023 | 1,600,000 | 745,336 | 461,279 | 0.65% |
Ares LXXIV CLO, Ltd. | Subordinated Notes (effective yield 11.22%, 10/15/2037) | 7/23/2025 | 4,000,000 | 3,141,285 | 1,898,956 | 2.68% |
Audax CLO 12, Ltd. | Subordinated Notes (effective yield 18.77%, 4/22/2037) | 3/03/2025 | 1,330,000 | 1,215,547 | 1,123,208 | 1.59% |
Ballyrock CLO 16, Ltd. | Subordinated Notes (effective yield 12.36%, 7/20/2034) | 8/20/2024 | 5,867,000 | 3,206,398 | 2,308,931 | 3.26% |
Ballyrock CLO 18, Ltd. | Subordinated Notes (effective yield 9.68%, 4/15/2038) | 8/16/2023 | 3,260,000 | 1,844,252 | 1,063,243 | 1.50% |
Barings CLO, Ltd. 2019-III | Subordinated Notes (effective yield 15.31%, 1/20/2036)6 | 12/13/2023 | 7,695,466 | 3,405,880 | 2,122,282 | 3.00% |
Barings CLO, Ltd. 2021-I | Subordinated Notes (effective yield 0.00%, 4/25/2034)8 | 7/17/2023 | 3,400,000 | 1,459,569 | 760,407 | 1.07% |
Barings CLO, Ltd. 2025-I | Subordinated Notes (effective yield 11.47%, 4/20/2038) | 2/14/2025 | 6,000,000 | 4,867,473 | 3,781,959 | 5.34% |
Barings CLO, Ltd. 2025-VIII | Subordinated Notes (effective yield 14.24%, 1/15/2039) | 12/03/2025 | 3,600,000 | 2,859,120 | 2,758,281 | 3.89% |
Benefit Street Partners CLO XXIII, Ltd. | Subordinated Notes (effective yield 20.08%, 4/25/2034) | 8/02/2023 | 10,000,000 | 5,995,262 | 5,182,323 | 7.31% |
Benefit Street Partners CLO XXXVIII, Ltd. | Subordinated Notes (effective yield 8.88%, 1/25/2038) | 12/17/2024 | 5,000,000 | 4,577,254 | 3,361,870 | 4.75% |
Birch Grove CLO 3, Ltd. | Subordinated Notes (effective yield 9.14%, 1/19/2038) | 9/4/2024 | 8,602,500 | 6,774,666 | 4,376,618 | 6.18% |
CIFC Funding 2020-II, Ltd. | Subordinated Notes (effective yield 11.49%, 10/20/2034) | 2/11/2025 | 9,032,000 | 4,567,308 | 3,470,369 | 4.91% |
Elmwood CLO 17, Ltd. | Subordinated Notes (effective yield 8.62%, 7/17/2037) | 8/13/2025 | 17,500,000 | 11,177,036 | 9,262,543 | 13.07% |
Elmwood CLO VII, Ltd. | Subordinated Notes (effective yield 5.36%, 1/17/2034) | 7/17/2023 | 3,400,000 | 1,542,041 | 827,546 | 1.17% |
Empower CLO 2022-1, Ltd. | Subordinated Notes (effective yield 9.46%, 10/20/2037) | 9/27/2024 | 9,500,000 | 7,233,696 | 4,181,068 | 5.90% |
Galaxy XXII CLO, Ltd. | Subordinated Notes (effective yield 6.31%, 4/16/2034) | 12/15/2023 | 3,560,000 | 1,923,511 | 986,151 | 1.39% |
MidOcean Credit CLO XI, Ltd. | Subordinated Notes (effective yield 14.23%, 1/18/2036) | 1/12/2024 | 6,250,000 | 3,713,384 | 2,275,269 | 3.21% |
MidOcean Credit CLO XIV, Ltd. | Subordinated Notes (effective yield 8.10%, 4/15/2037)6 | 2/15/2024 | 6,750,000 | 4,299,873 | 2,936,473 | 4.14% |
Neuberger Berman Loan Advisers CLO 41, Ltd. | Subordinated Notes (effective yield 12.45%, 4/15/2034) | 11/1/2023 | 4,500,000 | 2,402,581 | 1,298,962 | 1.83% |
Niagara Park CLO, Ltd. | Subordinated Notes (effective yield 15.25%, 1/17/2038) | 12/1/2023 | 7,850,000 | 4,268,420 | 2,694,351 | 3.80% |
Issuer (1)(7) | Investment Description | Acquisition Date (2) | Principal Amount | Cost | Fair Value (3) | % of Net Assets |
Niagara Park CLO, Ltd. | Subordinated Notes (effective yield 11.67%, 1/17/2038) | 11/6/2024 | $79,398 | $77,177 | $77,100 | 0.11% |
Oaktree CLO 2019-3, Ltd. | Subordinated Notes (effective yield 11.96%, 1/20/2038) | 6/12/2025 | 3,500,000 | 1,991,588 | 1,238,292 | 1.76% |
OCP CLO 2015-9, Ltd. | Subordinated Notes (effective yield 11.29%, 1/15/2037) | 12/6/2023 | 21,847,700 | 7,806,134 | 5,399,162 | 7.62% |
OCP CLO 2017-13, Ltd. | Subordinated Notes (effective yield 7.18%, 11/26/2037) | 5/13/2025 | 17,897,237 | 5,818,714 | 4,508,360 | 6.36% |
OHA Credit Partners XIII, Ltd. | Subordinated Notes (effective yield 11.65%, 10/21/2034) | 7/17/2023 | 2,950,000 | 1,668,496 | 1,143,912 | 1.61% |
Riverbank Park CLO, Ltd. | Subordinated Notes (effective yield 12.81%, 1/25/2038) | 11/4/2025 | 9,950,000 | 7,583,726 | 5,621,025 | 7.93% |
RR 12, Ltd. | Subordinated Notes (effective yield 0.00%, 1/15/2036)8 | 7/31/2024 | 8,542,000 | 1,457,461 | 983,474 | 1.39% |
RR 6, Ltd. | Subordinated Notes (effective yield 0.00%, 4/15/2036)8 | 4/25/2024 | 2,206,250 | 708,449 | 144,055 | 0.20% |
Silver Point CLO 4, Ltd. | Subordinated Notes (effective yield 14.64%, 4/15/2037) | 2/28/2025 | 7,140,000 | 4,480,506 | 1,843,769 | 2.60% |
Voya CLO 2020-2, Ltd. | Subordinated Notes (effective yield 11.22%, 7/19/2034) | 8/02/2023 | 13,597,500 | 9,740,815 | 7,235,149 | 10.21% |
Voya CLO 2020-3, Ltd. | Subordinated Notes (effective yield 10.62%, 1/20/2038) | 8/3/2023 | 5,798,000 | 3,710,656 | 2,673,436 | 3.77% |
Total CLO Equity | $170,431,325 | $120,487,050 | 170.06% | |||
CLO - Debt(4) | ||||||
Apidos CLO XXXIII, Ltd. | 12.22% (3M Term SOFR + 8.55%, 4/24/2038) | 4/23/2025 | $250,000 | $230,607 | $227,506 | 0.32% |
Total CLO Debt | $230,607 | $227,506 | 0.32% | |||
Real Estate(9) | ||||||
Moores Crossing - Travis County, TX | 7/14/2023 | $4,000,000 | $4,003,879 | $2,175,000 | 3.07% | |
Total Real Estate | $4,003,879 | $2,175,000 | 3.07% | |||
Total Investments | $174,665,811 | $122,889,556 | 173.45% | |||
Cash Equivalents | ||||||
City National Bank MMDA | Money Market Deposit Account | $2,037,879 | $2,037,879 | $2,037,879 | 2.88% | |
U.S. Bank MMDA | Money Market Deposit Account | 775,034 | 775,034 | 775,034 | 1.09% | |
Total Cash Equivalents | $2,812,913 | $2,812,913 | 3.97% | |||
Total Investments and Cash Equivalents | $177,478,724 | $125,702,469 | 177.42% |
Six Months Ended March 31, 2026 | ||
Investment Income | ||
Interest income | $12,661,704 | |
Total investment income | 12,661,704 | |
Expenses | ||
Interest expense | 5,539,868 | |
Management fees | 1,572,708 | |
Incentive fees | 253,737 | |
Professional fees | 659,687 | |
Administration and custodian fees | 331,722 | |
Insurance expense | 119,173 | |
Printing expense | 85,565 | |
Transfer agent fees | 89,255 | |
Trustees' fees and expenses | 62,329 | |
Other expenses | 58,757 | |
Total expenses | 8,772,801 | |
Net Investment Income | 3,888,903 | |
Net Realized and Unrealized Gain (Loss) | ||
Net realized gain (loss) on investments | (12,835,266) | |
Net change in unrealized appreciation (depreciation) on investments | (37,716,591) | |
Net Realized and Unrealized Gain (Loss) | (50,551,857) | |
Net Decrease in Net Assets Attributable to Common Shares from Operations | $(46,662,954) | |
Six Months Ended March 31, 2026 | Year Ended September 30, 2025 | |||
Net increase (decrease) in net assets from operations: | ||||
Net investment income | $3,888,903 | $15,208,865 | ||
Net realized gain (loss) on investment transactions | (12,835,266) | (17,706,825) | ||
Net change in unrealized appreciation (depreciation) on investments | (37,716,591) | (3,504,909) | ||
Net decrease in net assets resulting from operations | (46,662,954) | (6,002,869) | ||
Distributions to shareholders from: | ||||
Net investment income | (12,401,194) | (10,363,754) | ||
Return of capital | — | (13,459,803) | ||
Total distributions to shareholders | (12,401,194) | (23,823,557) | ||
Capital share transactions | ||||
Net increase (decrease) in net assets resulting from beneficial interest: | ||||
Issuance of common shares | — | 40,303,512 | ||
Reinvestment of dividends | — | 1,823,533 | ||
Net increase in net assets from capital share transactions | — | 42,127,045 | ||
Total increase (decrease) in net assets | (59,064,148) | 12,300,619 | ||
Net assets at the beginning of the period | 129,913,622 | 117,613,003 | ||
Net assets at the end of the period | $70,849,474 | $129,913,622 | ||
Six Months Ended March 31, 2026 | ||
Cash flows from operating activities | ||
Net decrease in net assets resulting from operations | $(46,662,954) | |
Adjustments to reconcile net decrease in net assets from operations to net cash provided by operating activities: | ||
Purchases of investments, net of change in payable for investments purchased | (14,513,070) | |
Proceeds from disposition of investments and reductions to investment cost value, net of change in receivable for investments sold (1) | 44,223,753 | |
Net amortization on investments | (332) | |
Amortization of deferred issuance costs on preferred shares and credit facility | 2,716,605 | |
Net realized loss on investments | 12,835,266 | |
Net change in unrealized depreciation on investments | 37,716,591 | |
Changes in assets: | ||
Decrease in interest receivable | 2,582,483 | |
Decrease in prepaid expenses and other assets | 119,172 | |
Changes in liabilities: | ||
Decrease in incentive fee payable | (417,006) | |
Increase in management fee payable | 87,989 | |
Decrease in interest payable on preferred shares | (105,147) | |
Decrease in professional fees payable | (429,547) | |
Increase in administration and custodian fees payable | 93,713 | |
Increase in other payables and accrued expenses | 217,195 | |
Net cash provided by operating activities | 38,464,711 | |
Cash flows from financing activities | ||
Borrowings on credit facility | 18,500,000 | |
Repayments on credit facility | (17,250,000) | |
Proceeds from the issuance of preferred shares | 47,500,000 | |
Deferred issuance costs for the issuance of preferred shares | (2,466,224) | |
Payments on preferred shares redeemed, net of redemptions payable | (72,000,000) | |
Dividends paid to shareholders | (12,401,194) | |
Net cash used in financing activities | (38,117,418) | |
Net increase in cash and cash equivalents | 347,293 | |
Cash and cash equivalents, beginning of period | 2,465,620 | |
Cash and cash equivalents, end of period | $2,812,913 |
Supplemental information: | ||
Cash paid for interest on preferred shares | $2,770,675 |
Six Months Ended March 31, 2026 | Year Ended September 30, | |||||||||
2025 | 2024 | 2023(7) | 2022 | |||||||
Per Share Operating Data | ||||||||||
Net asset value, beginning of period | $6.13 | $7.64 | $8.42 | $10.39 | $11.69 | |||||
Income (loss) from investment operations: | ||||||||||
Net investment income (1) | 0.18 | 0.81 | 1.19 | 0.05 | 0.50 | |||||
Net realized and unrealized gain (loss) (2) | (2.38) | (1.13) | (0.74) | (1.20) | (0.80) | |||||
Total from investment operations | (2.20) | (0.32) | 0.45 | (1.15) | (0.30) | |||||
Dividends to shareholders from: | ||||||||||
Net investment income (3) | (0.59) | (0.55) | (0.03) | (0.43) | (0.73) | |||||
Net realized gains (3) | — | — | — | — | (0.18) | |||||
Return of capital (3) | — | (0.71) | (1.20) | (0.40) | (0.09) | |||||
Total dividends | (0.59) | (1.26) | (1.23) | (0.82) | — | (1.00) | ||||
Effect of shares issued | $— | $0.07 | $— | $— | $— | |||||
Net asset value, end of period | $3.34 | $6.13 | $7.64 | $8.42 | $10.39 | |||||
Per share market value at beginning of period | $5.82 | $8.23 | $8.18 | $8.92 | $10.49 | |||||
Per share market value at end of period | $3.21 | $5.82 | $8.23 | $8.18 | $8.92 | |||||
Total Return based on Net Asset Value (4) | (38.29)% | (3.74)% | 6.07% | (11.75)% | (2.77)% | |||||
Total Return based on Market Value (5) | (36.94)% | (15.09)% | 17.21% | 0.39% | (5.95)% | |||||
Ratios/Supplemental Data | ||||||||||
Net assets, end of period (in thousands) | $70,849 | $129,914 | $117,613 | $98,751 | $107,829 | |||||
Ratio of gross expenses to average net assets (6) | 16.68% | 13.85% | 12.92% | 7.42% | 3.27% | |||||
Ratio of net expenses to average net assets (6) | 16.68% | 13.85% | 12.92% | 6.72% | 3.09% | |||||
Ratio of net expenses before incentive fees to average net assets (6) | 16.20% | 11.36% | 9.72% | N/A | N/A | |||||
Ratio of net investment income to average net assets (6) | 7.39% | 11.72% | 15.10% | 0.56% | 4.53% | |||||
Portfolio turnover rate | 17.33% | 28.91% | 17.69% | 100.91% | 28.39% | |||||
Asset coverage of preferred shares and credit facility | 220% | 258% | 285% | N/A | N/A | |||||
Loan Outstanding, End of Year/Period (in thousands) (8) | $8,000 | $6,750 | N/A | N/A | $7,455 | |||||
Asset Coverage Ratio for Loan Outstanding (8) | 1,623% | 3,143% | N/A | N/A | 1,546% | |||||
Asset Coverage, per $1,000 Principal Amount of Loan Outstanding (8) | $16,233 | $31,434 | N/A | N/A | $15,463 | |||||
Weighted Average Loans Outstanding (in thousands) (8) | $2,526 | $7,542 | N/A | $3,732 | $8,051 | |||||
Weighted Average Interest Rate on Loans Outstanding (8) | 7.09% | 7.45% | N/A | 7.94% | 4.50% | |||||
Senior Securities | ||||||||
Class and Period Ended | Total Amount Outstanding Exclusive of Treasury Securities (1) | Asset Coverage Per Unit (2) | Involuntary Liquidating Preference Per Unit (3) | Average Market Value Per Unit (4) | ||||
Credit Facility | ||||||||
March 31, 2026 | $8,000,000 | $16,233.31 | $— | N/A | ||||
September 30, 2025 | $6,750,000 | $31,434.17 | $— | N/A | ||||
8.75% Series A Term Preferred Shares | ||||||||
September 30, 2025 | $ | $64.48 | $25.00 | $25.74 | ||||
September 30, 2024 | $52,000,000 | $ | $ | $ | ||||
7.125% Series B Convertible Preferred Shares | ||||||||
March 31, 2026 | $3,517,000 | $2,200.49 | $1,000.00 | N/A | ||||
September 30, 2025 | $3,517,000 | $2,579.17 | $1,000.00 | N/A | ||||
September 30, 2024 | $11,517,000 | $ | $ | N/A | ||||
7.50% Series C Convertible Preferred Shares | ||||||||
September 30, 2025 | $20,000,000 | $2,579.17 | $1,000.00 | N/A | ||||
7.375% Series D Term Preferred Shares | ||||||||
March 31, 2026 | $30,000,000 | $55.01 | $25.00 | $25.17 | ||||
7.25% Series E Convertible Preferred Shares | ||||||||
March 31, 2026 | $17,500,000 | $2,200.49 | $1,000.00 | N/A |
As of March 31, 2026 | |||||||
Level 1 | Level 2 | Level 3 | Total | ||||
Assets | |||||||
Cash Equivalents | $2,812,913 | $— | $— | $2,812,913 | |||
Collateralized Loan Obligations | — | — | 120,714,556 | 120,714,556 | |||
Real Estate | — | — | 2,175,000 | 2,175,000 | |||
Total Investments, at Fair Value | $2,812,913 | $— | $122,889,556 | $125,702,469 | |||
For the Six Months Ended March 31, 2026 | ||||||
Collateralized Loan Obligations | Real Estate | Total | ||||
Balance, beginning of period | $190,028,718 | $2,175,000 | $192,203,718 | |||
Purchases of investments | 14,513,070 | — | 14,513,070 | |||
Proceeds from sales and paydowns of investments (1) | (33,275,707) | — | (33,275,707) | |||
Net realized gains (losses) | (12,835,266) | — | (12,835,266) | |||
Accretion of discount (premium) | 332 | — | 332 | |||
Net change in unrealized appreciation (depreciation) | (37,716,591) | — | (37,716,591) | |||
Balance, end of period | $120,714,556 | $2,175,000 | $122,889,556 | |||
Net change in unrealized appreciation (depreciation) included in earnings related to investments still held at the reporting date | $(42,245,835) | $— | $(42,245,835) | |||
As of March 31, 2026 | |||||||||
Carrying Value | Fair Value | Level 1 | Level 2 | Level 3 | |||||
Credit Facility (1) | $8,000,000 | $8,000,000 | $— | $— | $8,000,000 | ||||
7.125% Series B Convertible Preferred Shares (2) | 3,517,000 | 3,360,965 | — | — | 3,360,965 | ||||
7.375% Series D Term Preferred Shares (3) | 29,016,726 | 30,096,000 | 30,096,000 | — | — | ||||
7.25% Series E Convertible Preferred Shares (2) | 16,739,041 | 16,368,800 | — | — | 16,368,800 | ||||
Total | $57,272,767 | $57,825,765 | $30,096,000 | $— | $27,729,765 | ||||
Fair Value as of March 31, 2026 | Valuation Techniques | Significant Unobservable Inputs | Range | Weighted Average | |||||||
Low | High | ||||||||||
Collateralized Loan Obligations | $119,416,284 | Consensus Pricing | Indicative Quotes | 0.60% | 99.5% | 45.9% | |||||
$1,298,272 | Discounted Cash Flow | Discount Rate | 20.0% | 20.0% | 20.0% | ||||||
Real Estate | 2,175,000 | Market Approach | Bid Price | 54.4% | 54.4% | 54.4% | |||||
Total Level 3 Investments | $122,889,556 | ||||||||||
Total Facility | Borrowings Outstanding | Amount Available (1) | |||
Credit Facility | $30,000,000 | $8,000,000 | $22,000,000 |
Initial Issuance Date | Redemption Date | Dividend Rate | Share Amount | Price Per share | Total Raise | |
Series A Term Preferred Shares | 10/24/2023 | 11/3/2025 | 8.75% | 2,080,000 | $25.00 | $ |
Initial Issuance Date | Redemption Date | Dividend Rate | Share Amount | Price Per share | Total Raise | |
Series B Convertible Preferred Shares | 8/27/2024 | 8/27/2029 | 7.125% | 11,517 | $1,000.00 | $ |
As of March 31, 2026 | |
Series B Liquidation Preference | $3,517,000 |
Less: Unamortized deferred issuance costs(1) | — |
Carrying value | $3,517,000 |
Fair value | $3,360,965 |
Fair value price per share | $955.63 |
Initial Issuance Date | Redemption Date | Dividend Rate | Share Amount | Price Per share | Total Raise | |
Series C Convertible Preferred Shares | 1/31/2025 | 3/30/2026 | 7.50% | 20,000 | $1,000.00 | $ |
Initial Issuance Date | Redemption Date | Dividend Rate | Share Amount | Price Per share | Total Raise | |
Series D Term Preferred Shares | 10/30/2025 | 10/30/2028 | 7.375% | 1,200,000 | $25.00 | $30,000,000 |
As of March 31, 2026 | |
Series D Liquidation Preference | $30,000,000 |
Less: Unamortized deferred issuance costs | 983,274 |
Carrying value | $29,016,726 |
Fair value (1) | $30,096,000 |
Fair value price per share (1) | $25.08 |
Initial Issuance Date | Redemption Date | Dividend Rate | Share Amount | Price Per share | Total Raise | |
Series E Convertible Preferred Shares | 10/30/2025 | 10/30/2030 | 7.25% | 17,500 | $1,000.00 | $17,500,000 |
As of March 31, 2026 | |
Series E Liquidation Preference | $17,500,000 |
Less: Unamortized deferred issuance costs | 760,959 |
Carrying value | $16,739,041 |
Fair value | $16,368,800 |
Fair value price per share | $935.36 |
Outstanding Principal Balance as of | |
March 31, 2026 | |
Borrowings | |
Credit Facility | $8,000,000 |
Preferred Shares | |
Series B Convertible Preferred Shares | 3,517,000 |
Series D Term Preferred Shares | 30,000,000 |
Series E Convertible Preferred Shares | 17,500,000 |
Total | $59,017,000 |
Weighted average interest rate | 7.27% |
Six Months Ended March 31, 2026 | |
Federal tax cost of securities | $154,527,132 |
Gross unrealized appreciation | 20,138,679 |
Gross unrealized depreciation | (51,776,255) |
Net unrealized appreciation (depreciation) | $(31,637,576) |
Adviser | Carlyle Global Credit Investment Management L.L.C. |
Transfer Agent | Equiniti Trust Company LLC, (formerly known as American Stock Transfer & Trust Company) |
Legal Counsel | Dechert LLP |
Ticker Symbols | |
Common Shares | CCIF |
Preferred Shares | CCID |

(a)(1) | Not applicable for semi-annual reports. |
(a)(2) | Not applicable for semi-annual reports. |
(a)(3) | |
(b) |